PATRICK C. WALSH PROFESSORSHIP IN UROLOGY
Established in 1998 by Time Warner Inc. in honor of Patrick C. Walsh

PATRICK C. WALSH, director of Hopkins' Brady Urological Institute from 1974 to 2004, is known worldwide for his pioneering development of the surgical treatment for prostate cancer. Dr. Walsh developed a technique for removing the cancerous prostate that avoids the impotence and incontinence often associated with the traditional procedure. In 1996, Dr. Walsh received the prestigious Charles F. Kettering Prize, sponsored by General Motors Corporation, for "The Most Outstanding Recent Contributions to the Treatment of Cancer." Dr. Walsh is a member of the Institute of Medicine of the National Academy of Sciences, he serves on the editoral board of the New England Journal of Medicine, and for his 25 years of contributions as editor-in-chief of Campbell's Textbook of Urology the book has been renamed Campbell-Walsh. Dr. Walsh is a University Distinguished Service Professor of Urology.

 

TIME WARNER INC. is the world's leading media and entertainment company, whose businesses include filmed entertainment, interactive services, cable systems, television networks, and publishing.

 

Dr. ARTHUR (BUD) L. BURNETT, Med 1988, Bus 2009 (MBA), the Patrick C. Walsh Professor of Urology, received his AB degree in biology from Princeton University and MD and MBA degrees from The Johns Hopkins University. His post-graduate training in general surgery, urology, and reconstructive urology and urodynamics was performed at The Johns Hopkins Hospital. Dr. Burnett is a recognized expert in the areas of major pelvic reconstructions, voiding dysfunction, female urology, prostate cancer, and erectile dysfunction. This expertise is built on academic studies regarding the surgical anatomy of the pelvis, advances in surgical techniques of genital and pelvic reconstructive surgery, and basic science research contributions in the fundamental aspects of pelvic organ function. He has published extensively and lectures frequently in all these areas.

At Johns Hopkins medical institutions, he directs the Male Consultation Clinic for the treatment of male erectile dysfunction. He is recognized for the original discoveries of nitric oxide biochemical mechanisms in erectile tissue that paved the way for the clinical development of Viagra for erectile dysfunction. He has also pioneered work to develop therapies to protect penile nerve function for improving erectile function recovery after radical prostatectomy. He maintains an active National Institute of Health funded laboratory in neurourology.